CVS program seeks to encourage genetic testing of cancer patients

CVS is addressing the disconnect between availability of targeted cancer therapies and limited access to genetic tests through a precision medicine program that encourages next generation sequencing at the point of diagnosis.

The CVS Health Corp.

Read the full 353 word article

User Sign In